Louisville, KY, United States of America

Donghoon Chung

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Donghoon Chung: Innovator in Quinazolinone Inhibitors

Introduction

Donghoon Chung is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of quinazolinone inhibitors. With a total of 3 patents, his work focuses on innovative solutions for treating diseases associated with alphaviruses.

Latest Patents

Donghoon Chung's latest patents include advancements in 6-substituted quinazolinone inhibitors. The technology relates to compounds and compositions of Formulas I-III and methods using such compounds. These compounds and compositions may be utilized in the treatment or prophylaxis of diseases associated with an alphavirus, such as the Venezuelan equine encephalitis virus (VEEV).

Career Highlights

Throughout his career, Donghoon Chung has worked with esteemed institutions, including the University of Kansas Medical Center Research Institute and the University of Louisville Research Foundation, Inc. His research has contributed to the understanding and treatment of viral infections, showcasing his commitment to advancing medical science.

Collaborations

Some of his notable coworkers include Jennifer Elizabeth Golden and Jeffrey Aube. Their collaborative efforts have further enhanced the impact of his research in the field.

Conclusion

Donghoon Chung's innovative work in the development of quinazolinone inhibitors highlights his significant contributions to medicinal chemistry. His patents reflect a dedication to addressing critical health challenges associated with viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…